BridgeMD
Tests treatment safety and results for Hypoxia
Official title The Efficacy of Remimazolam on Incidence of Hypoxia During Sedated Transvaginal Oocyte Retrieval: A Multicenter Randomized Controlled Trial.
ClinicalTrials.gov ID: NCT07335536
What this study is testing
What is remimazolam-alfentanil combination?
remimazolam-alfentanil combination is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for hypoxia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Hypoxia is the most common adverse reaction during sedation outside the operating room.Exploring novel drug combinations to reduce the incidence of hypoxia during sedation in patients undergoing transvaginal oocyte retrieval procedures enhances patient safety and lowers perioperative adverse event rates. This multicenter, prospective, randomized, controlled clinical study will compare the hypoxia incidence rate of the remimazolam-alfentanil combination against the commonly used propofol-alfentanil combination.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50, women only
You may be able to join if
- people aged 18 to 50 years planning to undergo painless oocyte retrieval
- people classified as American Society of Anesthesiologists (ASA) physical status I-II
You likely can't join if
- people with contraindications to general anesthesia, acute or severe cardiovascular disease history, acute upper respiratory infection, chronic...
- people with alcohol abuse
- people with severe hepatic or renal insufficiency, severe cardiovascular disease, or psychiatric disorder history
- people with hearing impairment preventing communication
- people with a history of long-term sedative or opioid use, or allergies to benzodiazepines, flumazenil, opioids and their antidotes, propofol, eggs...
- people with SpO2 \< 95% while breathing room air after entering the room
The study team makes the final eligibility decision.
Where it's taking place
- Dongyang, Zhejiang, China
- Hangzhou, Zhejiang, China
- Lishui, Zhejiang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dongyang, Zhejiang, China; Hangzhou, Zhejiang, China; Lishui, Zhejiang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.